As I discussed in last week’s column, several long-running market trends have reversed this year. Bonds have beaten stocks.

Today's pharmaceutical stocks are facing the challenges of government-imposed drug price caps, waning demand for COVID-19 ...

Cellecor Gadgets Limited has completed the redemption of 250 unlisted, secured, redeemable, partly paid, non-convertible ...

In today’s unpredictable market shaped by trade tariffs, shifting global policies, and economic uncertainty, investors are searching for ...

Small-cap stocks have been among the biggest casualties during the historic stock-market selloff that followed President Donald Trump's tariff announcement Wednesday. That pain looked set to continue ...

BofA Securities is cautious about buying the Russell 2000 (NYSEARCA:IWM), after its 25% dip since November, due to fears of a ...

Small-cap stocks officially entered bear market territory on Thursday, seeing at least a 20% loss since their latest high.

A bill that aims to limit how much money can be reimbursed to large hospitals when treating patients who use a state employee ...

The iShares Russell 2000 ETF is in a bear market, down 21%, yet technical indicators hint at potential short-term gains.

Owning all three ETFs gives wide-ranging growth exposure with a diverse grouping of blue chips, small caps, and international stocks. You can confidently hold this combination and build on it, even if ...

Retail investors bought $4.7 billion in stocks on Thursday, the highest level over the past decade, JPMorgan said in a note ...

U.S. equity funds saw outflows in the week ending April 2 as investors shed risky assets on growing concerns that President ...